Literature DB >> 7997421

Dilated cardiomyopathy with 3-methylglutaconic aciduria.

J M Draaisma1, I C van Kesteren, O Daniëls, R C Sengers.   

Abstract

The case of an infant with both dilated cardiomyopathy and 3-methylglutaconic aciduria is presented. The literature on this subject is reviewed.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7997421     DOI： 10.1007/BF00817615

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  8 in total

1.  3-Methylglutaconic aciduria with persistent metabolic acidosis and 'uncoupling episodes'.

Authors:  O N Elpeleg; D Meiron; V Barash; Y Hurwitz; I Tal; N Amir
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Cardiac manifestations in disorders of fat and carnitine metabolism in infancy.

Authors:  T Ino; W G Sherwood; L N Benson; G J Wilson; R M Freedom; R D Rowe
Journal:  J Am Coll Cardiol       Date:  1988-06       Impact factor: 24.094

3.  Dilated cardiomyopathy with neutropenia, short stature, and abnormal carnitine metabolism.

Authors:  T Ino; W G Sherwood; E Cutz; L N Benson; V Rose; R M Freedom
Journal:  J Pediatr       Date:  1988-09       Impact factor: 4.406

4.  3-Methylglutaconic aciduria: a phenotype in which activity of 3-methylglutaconyl-coenzyme A hydratase is normal.

Authors:  K M Gibson; W L Nyhan; L Sweetman; K Narisawa; W Lehnert; P Divry; B H Robinson; K S Roth; F A Beemer; F J van Sprang
Journal:  Eur J Pediatr       Date:  1988-10       Impact factor: 3.183

5.  Phenotypic heterogeneity in the syndromes of 3-methylglutaconic aciduria.

Authors:  K M Gibson; W G Sherwood; G F Hoffman; D A Stumpf; I Dianzani; R B Schutgens; P G Barth; U Weismann; C Bachmann; P Schrynemackers-Pitance
Journal:  J Pediatr       Date:  1991-06       Impact factor: 4.406

6.  X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria.

Authors:  R I Kelley; J P Cheatham; B J Clark; M A Nigro; B R Powell; G W Sherwood; J T Sladky; W P Swisher
Journal:  J Pediatr       Date:  1991-11       Impact factor: 4.406

7.  An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes.

Authors:  P G Barth; H R Scholte; J A Berden; J M Van der Klei-Van Moorsel; I E Luyt-Houwen; E T Van 't Veer-Korthof; J J Van der Harten; M A Sobotka-Plojhar
Journal:  J Neurol Sci       Date:  1983-12       Impact factor: 3.181

Review 8.  Primary (genetic) cardiomyopathies in infancy. A survey of possible disorders and guidelines for diagnosis.

Authors:  A Kohlschütter; G Hausdorf
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183
  8 in total
  3 in total

Review 1.  Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit?

Authors:  Ying Huang; Meiyi Zhou; Haipeng Sun; Yibin Wang
Journal:  Cardiovasc Res       Date:  2011-05-01       Impact factor: 10.787

2.  Mitochondrial disease in superoxide dismutase 2 mutant mice.

Authors:  S Melov; P Coskun; M Patel; R Tuinstra; B Cottrell; A S Jun; T H Zastawny; M Dizdaroglu; S I Goodman; T T Huang; H Miziorko; C J Epstein; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

3.  "Omics" data integration and functional analyses link Enoyl-CoA hydratase, short chain 1 to drug refractory dilated cardiomyopathy.

Authors:  Nzali V Campbell; David A Weitzenkamp; Ian L Campbell; Ronald F Schmidt; Chindo Hicks; Michael J Morgan; David C Irwin; John J Tentler
Journal:  BMC Med Genomics       Date:  2018-12-12       Impact factor: 3.063
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.